{"url_path":"/sec/sptx/8-k/2026-06-08/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-08","source_url":"https://www.sec.gov/Archives/edgar/data/2042347/0001193125-26-260671-index.html","accession_number":"0001193125-26-260671","cik":"0002042347","ticker":"SPTX","issuer_name":"Seaport Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2042347/0001193125-26-260671-index.html","primary_entity_key":"0002042347","primary_entity_name":"Seaport Therapeutics, Inc."},"word_count":80,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n \n\n \n\nExhibit\n\nNumber\n\nDescription\n\n[99.1](sptx-ex99_1.htm)\n\nPress Release, dated June 8, 2026\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nSeaport Therapeutics, Inc\n\n \n\n \n\n \n\n \n\nDate:\n\nJune 8, 2026\n\nBy:\n\n/s/ Lauren White\n\n \n\n \n\n \n\nChief Financial Officer\n(Principal Financial Officer and Principal\nAccounting Officer)"}